Live Breaking News & Updates on Strazeneca

Stay informed with the latest breaking news from Strazeneca on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Strazeneca and stay connected to the pulse of your community

Vertex acquires Alpine for $4.9 billion in cash

The transaction is expected to close during the second quarter of 2024

Reshma-kewalramani , Alpine-immune-sciences , Vertex-pharmaceuticals , Vertex , Ertex-pharmaceuticals , Strazeneca , Usiness , Inance , Lpine-immune-sciences , Euralink , Ealth , Edical

Apple made $14 billion worth of iPhones in India last year

Plus: Airbus vs. Boeing.

India , China , Japan , Japanese , Morgan-haefner , Google , Airbus , Wells-fargo , Bmw , Intel , Boeing , Nvidia

Pfizer RSV shot trial shows protection for adults 18 to 59

There is currently no approved RSV vaccine for adults 18-59 years old

Pfizer , Drug-administration , Head-of-vaccine-research , Development-annaliesa-anderson , Senior-vice-president , Vaccine-research , Sv , Sv-vaccine , Strazeneca , Usiness , Inance

Biden, Sanders to take victory lap after drugmakers cap cost of inhalers

President Biden on Wednesday will tout Democrats’ efforts to lower the cost of inhalers after drugmakers announced plans to cap prices. The president, alongside Sen. Bernie Sanders (I-Vt.), will give remarks at the White House to highlight the crackdown on the cost of inhalers. They will also be joined by health care advocates and experts,…

White-house , District-of-columbia , United-states , United-kingdom , Senate-democrats , Boehringer-ingelheim , Democrats-in-congress , Astrazeneca , President-biden , Bernie-sanders , Inflation-reduction-act

AstraZeneca CEO 'deeply humbled' by award recognising pandemic efforts

AstraZeneca CEO Sir Pascal Soriot has been awarded one of the highest honours by science institution SCI for his role in ‘accelerating scientific innovation’ and for leading the company’s global COVID-19 vaccination programme.

Paul-drechsler , Pascal-soriot , Oxford-university , Astrazeneca , Sir-pascal , Biopharma-culture , Io-developments , Arkets-amp-regulations , Ovid-19 , Strazeneca , Ovid-19-vaccine

AstraZeneca Announces FDA Approval For Ultomiris

AstraZeneca (AZN.L, AZN) said Ultomiris has been approved in the United States as the first and only long-acting C5 complement inhibitor for the treatment of adult patients with anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.

United-states , Japan , More-such-health-news , European-union , Fda , Strazeneca , Ltomiris ,

Drugmakers Push Back Against Price Negotiations

Major pharmaceutical firms are fighting a new federal program that empowers the government to negotiate lower prices for drugs that are widely prescribed in the Medicare system. The Washington Post’s Tony Romm reports Monday that the companies are engaged in a “vigorous legal battle” to undo the new program, which was authorized by the Inflation Reduction Act signed into law by President Joe Biden in 2022. Last week, lawyers for four of the companies affected by the new rule – Bristol Myers Squi

Delaware , United-states , Washington , White-house , District-of-columbia , Joe-biden , Tony-romm , Novo-nordisk , Supreme-court , Bristol-myers-squibb , Novartis , Astrazeneca

Gracell Biotechnologies Announces Shareholders' Approval of

SAN DIEGO and SUZHOU, China and SHANGHAI, China, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (“Gracell” or the “Company”, NASDAQ:...

United-states , China , Cayman-islands , Shanghai , Suzhou , Jiangsu , American , Companies-act-as-revised-of-the-cayman , Nasdaq , Astrazeneca-treasury , Company-american-depositary

AstraZeneca's DKD pipeline highlights potential to differentiate in kidney disease space

In a recent quarterly update, AstraZeneca revealed that it removed tozorakimab from its phase 2 pipeline for diabetic kidney disease (DKD).

Kajal-jaddoo , Astrazeneca , Markets-amp-regulations , Io-developments , Ipelines , Merging-markets , Strazeneca , Idney-disease , Iabetes , Harmaceutical-industry ,

AstraZeneca's Tagrisso approved as an important new treatment option

Patients in the US with epidermal growth factor receptor mutated (EGFRm) advanced lung cancer can now receive an important new treatment option delaying disease progression by nearly nine additional months.

Switzerland , Canada , China , Japan , Australia , Laurie-ambrose , Dave-fredrickson , Drug-administration , Dana-farber-cancer-institute , Astrazeneca , Priority-review , New-england-journal